NCT02381886 2026-04-13A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 MutationsNovartisPhase 1 Active not recruiting166 enrolled
NCT06047379 2026-03-02Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisNeonc Technologies, Inc.Phase 1/2 Recruiting134 enrolled
NCT04985604 2025-10-02Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid TumorsDay One Biopharmaceuticals, Inc.Phase 2 Terminated23 enrolled 15 charts
NCT07121829 2025-08-14Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid TumorsDay One Biopharmaceuticals, Inc.Phase 1 Terminated44 enrolled